Goodwin Procter advised York Capital Management in its strategic growth investment in Comprehensive Rehab Consultants. William Blair acted as the sell-side investment banking advisor to CRC....
York Capital Management’s Partnership with Comprehensive Rehab Consultants
Kyowa Kirin’s $387 Million Acquisition of Orchard Therapeutics
Kyowa Kirin was represented by Goldman Sachs Japan Co., Ltd. as financial advisor and Morrison & Foerster LLP. as legal advisor. Orchard Therapeutics was represented by...
Eli Lilly’s $1.925 Billion Acquisition of Versanis Bio
Kirkland & Ellis acted as legal counsel to Eli Lilly, while for Versanis, Goodwin Procter acted as legal counsel and Cooley advised as to patent matters....
Thoma Bravo’s $2.8 Billion Acquisition of Ping Identity
Kirkland & Ellis represented Ping Identity, while Goodwin Procter represented Thoma Bravo in the transaction. Ping Identity (NYSE: PING), provider of the Intelligent Identity solution for...
Generate Biomedicines’ Research Collaboration Agreement with Amgen
Goodwin advised Generate Biomedicine on the deal. Generate Biomedicines announced its research collaboration agreement with Amgen (NASDAQ: AMGN) to discover and create protein therapeutics for five clinical...
Omega Therapeutics’ $144.6 Million IPO
Goodwin Procter advised Goldman Sachs & Co. LLC and the other underwriters on the deal. Omega Therapeutics, Inc. (Nasdaq: OMGA), a development-stage biotechnology company leveraging its OMEGA...